Nivel 5 ATC
C09CA04 - Irbesartan
135 medicamente în această clasă
Medicamente (12)
| Nume comercial | DCI | Concentrație | Producător |
|---|---|---|---|
| APROVEL 150mg | Irbesartanum | 150mg | Sanofi Winthrop Industrie - Franta |
| APROVEL 300mg | Irbesartanum | 300mg | Sanofi Winthrop Industrie - Franta |
| APROVEL 75mg | Irbesartanum | 75mg | Sanofi Winthrop Industrie - Franta |
| IFIRMASTA 75 mg | Irbesartanum | 75mg | Krka ,d.d., Novo Mesto - Slovenia |
| IRBESARTAN TERAPIA 150 mg | Irbesartanum | 150mg | Terapia Sa - Romania |
| IRBESARTAN TERAPIA 300 mg | Irbesartanum | 300mg | Terapia Sa - Romania |
| IRBESARTAN TEVA 150 mg | Irbesartanum | 150mg | Teva Pharm. Works Private Ltd. Company - Ungaria |
| IRBESARTAN TEVA 300 mg | Irbesartanum | 300mg | Teva Pharm. Works Private Ltd. Company - Ungaria |
| IRBESARTAN TEVA 75 mg | Irbesartanum | 75mg | Teva Pharm. Works Private Ltd. Company - Ungaria |
| IRBESARTAN ZENTIVA 150mg | Irbesartanum | 150mg | Sanofi Winthrop Industrie - Franta |
| IRBESARTAN ZENTIVA 300mg | Irbesartanum | 300mg | Sanofi Winthrop Industrie - Franta |
| IRBESARTAN ZENTIVA 75mg | Irbesartanum | 75mg | Sanofi Winthrop Industrie - Franta |
Substanțe active în C09CA04
Proprietăți chimice
Sursă: PubChem (NIH) · CID 3749
- Formula moleculară
- C25H28N6O
- Greutate moleculară
- 428.5 g/mol
- Număr CAS
- 138402-11-6
- InChIKey
- YOSHYTLCDANDAN-UHFFFAOYSA-N
- Denumire IUPAC
- 2-butyl-3-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]-1,3-diazaspiro[4.4]non-1-en-4-one